RaiaDrogasil
RADL3.SA
#2084
Rank
C$10.53 B
Marketcap
$6.14
Share price
-1.51%
Change (1 day)
-24.55%
Change (1 year)

P/E ratio for RaiaDrogasil (RADL3.SA)

P/E ratio as of November 2024 (TTM): 34.8

According to RaiaDrogasil's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 34.8134. At the end of 2022 the company had a P/E ratio of 38.4.

P/E ratio history for RaiaDrogasil from 2009 to 2023

PE ratio at the end of each year

Year P/E ratio Change
202238.4-28.06%
202153.3-14.35%
202062.330.66%
201947.628.14%
201837.2-37.25%
201759.331.59%
201645.031.12%
201534.3-8.89%
201437.7-22.05%
201348.4-34.7%
201274.0106.23%
201135.930.73%
201027.526.89%
200921.6

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.